Dr. Mike Trangle

And so they get reported and then they become officially, officially the official, you know, and that's the challenge we have today. So, you know, all you can do, I think, is just stick with the track record and, you know, acknowledge what you know and what you don't know. So I think that's it.

And so they get reported and then they become officially, officially the official, you know, and that's the challenge we have today. So, you know, all you can do, I think, is just stick with the track record and, you know, acknowledge what you know and what you don't know. So I think that's it.

The question you raised about the biologics, the irony about this is it's not in many cases a big challenge. And why? Because the kinds of immune compromising conditions that these drugs cause, like enhancing TB or things like that, are frankly diseases of low and middle income countries, not high income countries. And they're only selling these drugs in high income countries.

The question you raised about the biologics, the irony about this is it's not in many cases a big challenge. And why? Because the kinds of immune compromising conditions that these drugs cause, like enhancing TB or things like that, are frankly diseases of low and middle income countries, not high income countries. And they're only selling these drugs in high income countries.

So if you were to take the same drug and deliver it to Gaza right now, you would have a very different side effect, you know, the implications for, you know, any kind of adverse event, very different than if you gave it to the people who attend the University of Minnesota, you know, cancer clinics. And so that's the biggest issue we have today is that

So if you were to take the same drug and deliver it to Gaza right now, you would have a very different side effect, you know, the implications for, you know, any kind of adverse event, very different than if you gave it to the people who attend the University of Minnesota, you know, cancer clinics. And so that's the biggest issue we have today is that

And for most of these drugs, they're not going to be a problem for us other than, you know, the other immunologic issues it might cause. But this is why these drugs are never meant for the low and middle income countries. They couldn't afford them to begin with. And second of all, that's where the real challenges are with the diseases.

And for most of these drugs, they're not going to be a problem for us other than, you know, the other immunologic issues it might cause. But this is why these drugs are never meant for the low and middle income countries. They couldn't afford them to begin with. And second of all, that's where the real challenges are with the diseases.

Well, you know, this is an interesting one, because this is another one where I got crosswise with some people. You know, I have served in every presidential administration since Ronald Reagan, some official role. During the Trump administration, I was actually the science envoy for the State Department and pandemic preparedness for the world, ironically.

Well, you know, this is an interesting one, because this is another one where I got crosswise with some people. You know, I have served in every presidential administration since Ronald Reagan, some official role. During the Trump administration, I was actually the science envoy for the State Department and pandemic preparedness for the world, ironically.

So and I was on the Biden-Harris transition team for COVID. So that, you know, no one, I think, hopefully would accuse me of being politically motivated. You know, my job has always just been a private in the public health army and report to duty and do what I can to help. Okay.

So and I was on the Biden-Harris transition team for COVID. So that, you know, no one, I think, hopefully would accuse me of being politically motivated. You know, my job has always just been a private in the public health army and report to duty and do what I can to help. Okay.

So I think from that standpoint, that's really an important point is, you know, just basically put it out there as you do. But again, the challenges that I saw often were coming from my own colleagues in public health who were had points of view that, you know, differed and therefore they, they, they, that became the battleground and the public is sitting there listening to this. Okay.

So I think from that standpoint, that's really an important point is, you know, just basically put it out there as you do. But again, the challenges that I saw often were coming from my own colleagues in public health who were had points of view that, you know, differed and therefore they, they, they, that became the battleground and the public is sitting there listening to this. Okay.

You know, what, what does it mean? Not mean. And I think that that's the challenge that we had was there's not a way to come up with a single public health voice. I understand that. I agree with that. Um, And there's not a way to understand outreach.

You know, what, what does it mean? Not mean. And I think that that's the challenge that we had was there's not a way to come up with a single public health voice. I understand that. I agree with that. Um, And there's not a way to understand outreach.

A good example in Clarence, I know that you're probably likely very aware of this, but one of the most wonderful, absolutely incredible activities that took place during the pandemic was the Black Barbers and Black Hairstylists programs, where the group out of the University of Maryland in particular were working on Black Barbers. And I got very involved with this.

A good example in Clarence, I know that you're probably likely very aware of this, but one of the most wonderful, absolutely incredible activities that took place during the pandemic was the Black Barbers and Black Hairstylists programs, where the group out of the University of Maryland in particular were working on Black Barbers. And I got very involved with this.

I even had my own name, Big Mike, okay, in this program. I mean, I love these guys. And their outreach was remarkable because they knew how to outreach. And when they were sitting in that barber chair and they had their trusted barber who now, because they had taken courses and they were being educated on the current issues, they became trusted voices in the community.

I even had my own name, Big Mike, okay, in this program. I mean, I love these guys. And their outreach was remarkable because they knew how to outreach. And when they were sitting in that barber chair and they had their trusted barber who now, because they had taken courses and they were being educated on the current issues, they became trusted voices in the community.